There is an educational need for expert consensus on what constitutes acceptable multidisciplinary team meeting practice.  A need for discussion and case reviews to characterize the disease, management decisions and formulating diagnosis may also be part of the discussion.

LINK:

OBJECTIVES: Upon completion of this activity, the participant should be able to:

(1) Identify risk factors and benefits of treatment options for interstitial lung disease

(2) Formulate differential diagnoses in patients with interstitial lung disease

(3) Identify signs and symptoms of lung disease

(4) Identify the most sensitive and specific diagnostic testing available for disease workup

PLANNER/MODERATOR DISCLOSURE: The planner, Michael Duncan, MD has no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

PLANNER/MODERATOR DISCLOSURE: Susan Mathai, MD has relevant financial relationships with Forsee Pharmaceuticals, Cumberland Pharmaceuticals, a TyrPharma, Icahn School of Medicine at Mount Sinai, National Jewish Health, National Institutes of Health, Department of Defense, University of Colorado as a Clinical Trail Principal Investigator. Also, Veronica Pharmaceuticals and receive an honoraria and as a Medical Advisory Board. 

PLANNER/MODERATOR DISCLOSURE: Yolanda Mageto, MD has relevant financial relationships with Boehringer Ingelheim Pharmaceuticals Inc., Behring Pharmaceuticals, NeRRe Therapeutics, Daewong Pharmaceuticals, PureTech LYT 100 Inc., Tvardi Therapeutics, Bellerophon Pulse Technologies LLC, Fibro Gen Inc., Celgene Corporation, AstraZeneca Pharmaceuticals, AM MAX Bio Inc. and receives a honoraria as a speaker as a Clinical Trail Principal Investigator.

PLANNER/MODERATOR DISCLOSURE: Yosafe Wakwaya, MD has a relevant financial relationship with United Therapeutics Corporation for TETON PI status as a researcher.

All relevant financial relationships have been mitigated

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
 

For assistance please contact: Shannon Jackson at Shannon.Jackson@BSWHealth.org